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Abstract
Background: Considerable evidence indicates that heparan sulfate is essential for the development of tissues consisting of
branching ducts and tubules. However, there are few examples where specific sulfate residues regulate a specific stage in
the formation of such tissues.
Methodology/Principal Findings: We examined the role of heparan sulfation in mammary gland branching morphogenesis,
lactation and lobuloalveolar development by inactivation of heparan sulfate GlcNAc N-deacetylase/N-sulfotransferase genes
(Ndst) in mammary epithelial cells using the Cre-loxP system. Ndst1 deficiency resulted in an overall reduction in
glucosamine N-sulfation and decreased binding of FGF to mammary epithelial cells in vitro and in vivo. Mammary epithelia
lacking Ndst1 underwent branching morphogenesis, filling the gland with ductal tissue by sexual maturity to the same
extent as wildtype epithelia. However, lobuloalveolar expansion did not occur in Ndst1-deficient animals, resulting in
insufficient milk production to nurture newly born pups. Lactational differentiation of isolated mammary epithelial cells
occurred appropriately via stat5 activation, further supporting the notion that the lack of milk production was due to lack of
expansion of the lobuloalveoli.
Conclusions/Significance: These findings demonstrate a selective, highly penetrant, cell autonomous effect of Ndst1-
mediated sulfation on lobuloalveolar development.
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Introduction
Mammary gland development occurs in multiple stages: (i) fetal
development of the rudimentary mammary buds, (ii) branching
morphogenesis in immature animals, (iii) formation of lobular
alveoli during pregnancy, (iv) differentiation of milk-producing
epithelia and lactation, and (v) involution after weaning. The
classical endocrine hormones (estrogen, progesterone, growth
hormone, and prolactin) regulate these developmental processes
by acting on the mammary stroma to induce the local expression
of soluble growth factors [1].
Based on genetic studies, a large family of growth factors
regulate these processes, including fibroblast growth factors
(FGFs), Wnts, parathyroid hormone-related protein (PTHrP),
Hedgehog proteins (Hh and Ihh), transforming growth factor beta
(TGFb) and inhibin-bb, insulin-like growth factor(IGF)-I and -II
and IGF-binding protein-5 (IGFBP-5), hepatocyte growth factor
(HGF), amphiregulin, epidermal growth factor (EGF) and
EGF receptors, and heregulin (HRG) and ERBB4 receptors
[2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]. Nearly all
of these factors bind to heparan sulfate, a glycosaminoglycan
present in extracellular matrix and cell surface proteoglycans.
Interaction with heparan sulfate is hypothesized to protect growth
factors against degradation, to create a storage depot for later
release, to facilitate assembly of signaling complexes (co-receptor
activity), to enable clearance by endocytosis, and to regulate
growth factor diffusion through the tissue [22,23,24]. Heparan
sulfate also can act indirectly in the system, e.g. by modulating the
processing of growth factor precursors by matrix metalloproteases
[25].
Heparan sulfate was one of the first extracellular matrix
components identified in the developing mammary gland.
Midpregnant mice produce glycosaminoglycans (GAGs) in the
basal lamina and the surrounding matrix, including heparan
sulfate and hyaluronan. GAG production appeared to be
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end buds during puberty and during pregnancy [26]. Sulfated
GAGs were found in the posterior (neck) region of the terminal
end bud in the epithelia, stroma and elsewhere [27]. Further
evidence supporting a role for heparan sulfate in mammary
development derives from studies of genetically altered mouse
strains. For example, hyperbranching occurs in the mammary
epithelia of transgenic mice expressing human heparanase, a
degradative enzyme secreted by cells [28]. Mice deficient in
syndecan-1, a cell surface heparan sulfate proteoglycan expressed
by mammary epithelial cells, exhibit normal primary mammary
duct formation, but have a mild reduction in secondary and
tertiary branching [29,30]. In CD44
2/2 mice, postpartum uterine
involution is accelerated and maintenance of lactation is impaired,
presumably due to mislocalization of matrix metalloproteinase 7
and altered processing of proHB-EGF [31]. In some cases, the
mechanism responsible for these developmental alterations has not
been characterized, and one cannot discriminate cell-autonomous
effects in the mammary epithelia versus stromal effects since the
mutations were systemic. Mutants lacking other heparan sulfate
proteoglycans either succumb embryonically [32], obviating
further studies of the mammary gland, or have no reported
defects in mammary gland development or function
[33,34,35,36,37].
In general, the essential nature of heparan sulfate has made it
difficult to study the effect of altering its biosynthesis in the
mammary gland in vivo. Systemic deletion of Ext1 or Ext2
(subunits of the heparan sulfate copolymerase) results in early
embryonic death (E6-7) due to failure to form mesoderm during
gastrulation [38,39]. Deletion of the gene encoding heparan
sulfate GlcNAc N-deacetylase/N-sulfotransferase-1 (Ndst1), one of
a family of four enzymes involved in the initial sulfation of the
heparan sulfate chains, leads to perinatal lethality with lung, brain
and skeletal defects [40,41,42]. Similarly, deletion of two other
modifying enzymes, uronyl 2-O-sulfotransferase and the glucur-
onyl C5 epimerase, causes perinatal death due to kidney agenesis
[43,44,45,46]. In other organs, such as kidney, lung and salivary
gland, defects in heparan sulfation have mainly been shown to
affect branching morphogenesis [47], although the mechanism
may not be as straight-forward as initially believed [48]. However,
most of this work has been done using in vitro systems.
To study the in vivo role of heparan sulfate in the mammary
gland, we used the Cre-loxP recombination system to delete Ndst1
in a tissue-specific manner in mammary epithelia. Somewhat
surprisingly, we found that inactivation of Ndst1 does not affect
branching morphogenesis or lactational differentiation, but instead
causes a striking defect in lobuloalveolar expansion leading to
insufficient milk production for survival of offspring.
Results
Ndst expression and targeting
Heparan sulfate assembly occurs by copolymerization of N-
acetylglucosamine (GlcNAc) and glucuronic acid (GlcA) residues,
followed by a series of modification reactions in which segments of
the chain undergo various sulfation reactions and a portion of the
GlcA units epimerize to iduronic acid [49] (Fig. 1A). N-
deacetylation and N-sulfation of subsets of the GlcNAc residues
represents the first committed step in modifying the chains and the
other modifications depend on this reaction. A family of four dual
function enzymes, designated GlcNAc N-deacetylase/N-sulfo-
transferases (Ndsts) exists in vertebrates [50]. RT-PCR analysis
showed that mammary epithelia express Ndst1 and Ndst2 but
negligible levels of Ndst3 and Ndst4 (Fig. 1B). To determine the
effects of altering the extent of heparan sulfation on mammary
gland development, deletion mutants of Ndst1 and Ndst2 were
examined.
Ndst2 null animals lack connective tissue-type mast cells but are
otherwise normal [51,52]. In contrast, mice lacking Ndst1 die
perinatally due to lung insufficiency, as well as displaying skeletal
and forebrain defects [40,41,42]. Thus, to examine the participa-
tion of Ndst1 in the mammary gland, Ndst1 was inactivated
selectively in mammary epithelial cells by cross breeding mice
bearing a floxed conditional allele (Ndst1
f/f)t oMMTVCre mice,
which express the bacteriophage Cre recombinase in mammary
epithelia at day 6 postpartum [53,54]. These mouse lines were
interbred to generate Ndst1
f/fMMTVCre
+ (mutant) and Ndst1
f/f
MMTVCre
2 (wildtype) mice. Both genotypes were obtained at the
expected Mendelian frequency and appeared grossly normal.





2 virgin and uniparous female
mice and expanded in tissue culture. Evaluation of markers for
epithelial keratin and milk proteins indicated .90% purity. DNA
isolated from the cells was analyzed by HindIII/BamHI digestion
and Southern blotting. The wildtype ‘‘floxed’’ Ndst1 allele
generated a 2.7 kb band, whereas the deleted allele yielded a
3.2 kb band, based on analysis of clonal mammary epithelial cell
lines derived from Ndst1
f/f before and after Cre transfection in
Figure 1. Inactivation of Ndst1 in mammary epithelia. (A)
Schematic diagram of heparan sulfate synthesis. The target gene, Ndst1,
is shown in red. (B) RT-PCR analysis of Ndst expression in isolated
epithelial cells. The ramp at top indicates increasing number of PCR
amplification cycles. (C) Mammary epithelial cells were isolated from a
virgin (lane 3) and a 3-month old uniparous female (lane 4) and
analyzed by Southern blotting. For comparison, blots were performed
on samples obtained from Ndst1 deficient (lane 1) and Ndst1
f/f (lane 2)
mammary tumor cell lines (Experimental Procedures). Ndst1 deletion
was approximately 60% complete in adult virgin mice and increased to
,80% after one pregnancy.
doi:10.1371/journal.pone.0010691.g001
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that deletion of Ndst1 in Ndst1
f/f MMTVCre
+ was as high as ,80%
in multiparous females (Fig. 1C), suggesting that some cells
escaped recombination, possibly due to inefficient expression of
Cre. Unless otherwise indicated, multiparous females were used in
the in vivo studies that follow. In some work with isolated cells,
.95% deletion was achieved by inactivating the gene use
adenoviral Cre.
Ndst1 deficiency causes undersulfation of heparan sulfate
in mammary ducts
To determine how Ndst1 deficiency affected heparan sulfate of





+ mammary glands were incubated with a
biotinylated form of basic fibroblast growth factor (FGF2) and then
stained with streptavidin-horse radish peroxidase [55]. FGF2 binds
with high affinity to heparan sulfate in many tissues [56] and a
distinct border of bound FGF2 was found surrounding the luminal
epithelia and myoepithelia, in a pattern characteristic of basement
membranes (arrowheads, Fig. 2A). Ndst1
f/fMMTVCre
+ mammary
ducts displayed reduced binding of FGF2 in the basement
membrane, while no change was observed in the staining of the
mammary fat pad heparan sulfate (open arrowheads), consistent
with the selective expression of Cre in the epithelial lineage.
Mammary glands isolated from the Ndst2
2/2 animals resembled
wildtype (data not shown), which is consistent with the lack of
effect of Ndst2-deficiency on the heparan sulfate composition in
most tissues [57].
Heparan sulfate was also analyzed chemically utilizing primary





– females. In these experiments,
cells were labeled with [6-
3H]glucosamine in culture, and labeled
heparan sulfate was purified and the backbone of the polymer was
cleaved at each N-sulfated glucosamine unit by treatment with
nitrous acid at low pH [58]. The resulting oligosaccharides were
then separated by gel filtration chromatography (Fig. 2B). Wild-
type heparan sulfate was typically rich in N-sulfated glucosamine
residues located in adjacent disaccharides (dp2) or separated by
one or two N-acetylated disaccharides (dp4 and dp6, respectively).
In contrast, heparan sulfate produced by the mutant cells
contained fewer of these smaller oligosaccharides and more
extended structures rich in N-acetylated disaccharides (dp.18)
were present. The areas under the peaks can be used to estimate
the extent of N-sulfation of the chains [59]. Using this technique,
heparan sulfate synthesized in the primary cells derived from
Ndst1
f/fMMTVCre
+ cells displayed a ,2-fold reduction in N-
sulfation (,45% GlcNS in Ndst1
f/fMMTVCre
– cells vs. ,25% in
Ndst1
f/fMMTVCre
+ cells) (Fig. 2C, inset). This decrease in GlcNAc
N-deacetylation/N-sulfation is comparable to effects seen in
mutant CHO cells lacking Ndst1 [59] and in tissues derived from
mice bearing a systemic null allele of Ndst1 [41,57,60]. The FGF2
binding data (Fig. 2A) and the chemical analysis (Figs. 2B) indicate
that Ndst1 deficiency reduces the overall level of N-sulfation, which
in turn can affect binding of heparin-binding growth factors of
which FGF2 is a prototypical example.
Normal branching morphogenesis but defective
lobuloalveolar development in absence of Ndst1
In wildtype mice, branching morphogenesis within the
mammary gland occurs from birth to sexual maturity. By one
month of age extensive branching has taken place, but the glands
have not filled completely. Whole mount glands from one-month
old Ndst1
2/2 mice appeared normal with respect to the extent of
fat pad colonization, overall branching, and the presence of
terminal end buds (Fig. 3A,B). Histological examination of
hematoxylin/eosin-stained sections showed similar ductal density
and similar gross arrangement of the surrounding connective tissue
cells (Fig. 3C,D). Comparable results were observed in 3-month
old sexually mature animals as well, when the fat pad is filled
completely and branching has ceased (Fig. 3E,F). Numerous
glands from animals randomized with respect to the estrus cycle
were examined without any consistent differences in the glands.
Thus, altering Ndst1 expression in glands had minimal effects on
branching morphogenesis.
Ndst1-deficient mice gave birth to normal size litters, but less
than 30% of the offspring from Ndst1-deficient females survived
more than ,1.5 days postpartum and the surviving pups were
small. Fostering the pups with lactating female ICR mice allowed
for normal development of pups, whereas ICR pups fostered to the
Ndst1
f/fMMTVCre
+ females perished shortly after the transfer.
Necropsy revealed empty stomachs, suggesting that the Ndst1-
deficient mothers did not properly lactate. Ndst2-deficient females
yielded pups that thrived normally.
Whole mounts of day 1 lactating (D1L) mammary glands from
multiparous Ndst1
f/fMMTVCre
+ females revealed dramatically
retarded lobuloalveolar expansion compared to lactating glands
from wildtype animals (compare Figs. 4A and 4B), whereas whole
mounts of multiparous non-pregnant Ndst1
f/fMMTVCre
+ females
looked normal (data not shown). Hematoxylin/eosin stained
sections at day 1 of lactation indicated that the cellular
architecture of the mammary ducts was normal, however the
lobuloalveoli were reduced in size and number (compare Figs. 5C
and 5F). Analysis of stained sections of tissues obtained at earlier
time points revealed that the disruption in lobuloalveolar
development was not apparent at day 8 of pregnancy (compare
Fig. 5A and 5D), but was already manifest by day 15 of
pregnancy (Fig. 5B and 5E) where a slight reduction in





2 females. This reduction at d15P
is quantified in Figure 5G.
Transplantation of Ndst1
f/fMMTVCre
+ glands into wild-
type mice
In order to confirm the epithelial autonomy of this phenotype,
Ndst1
f/fMMTVCre
+ epithelia were transplanted into the wild type
fat pad cleared of epithelia from the inguinal gland. The host
animals were bred two months later and whole mounts of the
glands were analyzed at day 1 of lactation (D1L). Control wildtype
fat pads receiving no epithelia remained devoid of ductal
structures (data not shown), whereas those that received wildtype
epithelia were normal (Fig. 4C). Glands receiving Ndst1
f/f
MMTVCre
+ epithelia (Fig. 4D) underwent ductal branching
normally but exhibited the same reduced alveolar expansion seen
in glands from D1L Ndst1
f/fMMTVCre
+ females (Fig. 4B). This
finding confirmed that the lactation defect was due to the deletion
of Ndst1 specifically in the mammary epithelia.




To further characterize the defect in the Ndst1
f/fMMTVCre
+
females, casein and whey acidic protein (WAP) expression was
analyzed. By quantitative PCR, the level of mRNAs of these
proteins relative to GAPDH was dramatically reduced in d1L
glands from Ndst1
f/fMMTVCre
+ mice compared to Ndst1
f/f
MMTVCre
– mice (Fig. 6A). However, the decrease in milk protein
expression paralleled changes in keratin 18 mRNA (Fig. 6A) and
Mammary Gland Heparan Sulfate
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f/fMMTVCre
+ mammary epithelia. (A) Frozen sections of mammary glands were
incubated with biotinylated FGF2, which binds to heparan sulfate [55]. Binding of FGF2 was detected with streptavidin-HRP (brown stain). In wildtype
Ndst1
f/fMMTVCre
– glands FGF2 binds to the basement membrane surrounding the epithelial ducts (arrowheads). The right panel magnifies the boxed
region, revealing the sharp staining of the basement membrane underlying the epithelial cells. FGF2 also binds to the matrix surrounding the fat pad
adipocytes (white arrowheads). Mutant Ndst1
f/fMMTVCre
+ glands retain FGF2 binding around fat pad adipocytes, but binding to the basement
membranewasgreatlyreduced. Thelowerrightpanelmagnifies the boxedregion. Thebarintheleft panels =50 mm,right panels 12.5 mm.(B) Heparan
sulfate was isolated from [6-




+ mice and degraded
with nitrous acid [58]. The individual oligosaccharides were separated by gel filtration chromatography and the area under the peaks was used to
determine the extent of N-sulfation of the chains [59]. dp, degree of polymerization. Inset: Graph of comparison of areas under the curves.
doi:10.1371/journal.pone.0010691.g002
Mammary Gland Heparan Sulfate
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epithelial cells, suggesting that the reduced capacity to produce
milk might be related to the decrease in the number and size of
lobuloalveoli rather than a defect in differentiation. Western
blotting with antibodies to mouse milk from d1L glands showed
that milk production was diminished in Ndst1
f/fMMTVCre
+ glands
nearly to the same extent as keratin expression (Fig. 6C). Analysis
of day 14 pregnant (d14P) glands showed that the antiserum was
specific for milk proteins.
The aforementioned results suggested normal differentiation
despite markedly decreased lobuloalveolar development. To
confirm that differentiation was normal, primary mammary
epithelial cells from mature Ndst1
f/f females were plated on
serum/fetuin coated plates and treated with adenoviral Cre
(AdCre), which resulted in .95% deletion of Ndst1
f/f allele. Passage
of the cells in the presence of lactogenic hormones and Matrigel
induced the epithelia to undergo differentiation into a lactational
state in AdCre-treated cells and in cells infected with a control virus
containing GFP (Fig. 7A). Normal lactation has been shown to
require signaling through the prolactin receptor, which activates
milk protein gene transcription through the phosphorylation of
Stat5. Western blotting with anti-phospho-Stat5 antibodies con-
firmed that proper signaling had occurred (Fig. 7B). Taken
together, the data show that differentiation was normal in Ndst1-
deficient glands and that the paucity of milk was due to a defect in
the proliferation of the epithelial population required for lactation.
Discussion
Mouse mammary development proceeds through multiple
morphologically well-defined steps. After birth, the epithelial
placode undergoes branching morphogenesis from a rudimentary
branched structure to a fully branched ductal tree that fills the fat
pad. During pregnancy, further secondary and tertiary branching
occurs and alveoli appear along the ducts, resulting eventually in
the formation of lobuloalveoli that can differentiate into milk
producing glands under the influence of lactogenic hormones.
After weaning, the gland involutes by apoptosis of the epithelial
Figure 3. Branching morphogenesis is normal in NDST deficient epithelial cells. Whole mounts of the inguinal mammary glands were used
to examine branching morphogenesis of one-month old Ndst1
f/fMMTVCre
– (Wildtype, A), and Ndst1
f/fMMTVCre
+ (Ndst1
–/–, B) females. Deficiency of
Ndst1 has no effect on branching morphogenesis. Histological analysis of glands from one-month old animals showed normal organization of ductal
epithelium (C,D). Whole mounts of 3 month-old glands also show normal branching (E,F). Bar =1.5 mm in the upper panels, 100 mm in the middle
panels, and 1 mm in the lower panels. n, lymph node.
doi:10.1371/journal.pone.0010691.g003
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process depends on a series of growth factors, many of which can
interact with heparan sulfate [23].
To examine if these interactions are necessary for post-natal
mammary development, we reduced the level of sulfation of the
chains by inactivating Ndst1 using the Cre recombinase under the
control of the MMTV promoter. At least 80% knockout was
achieved in the in vivo experiments and .95% deletion was
achieved in vitro. Because this system depends on hormonal
activation during the estrous cycle, we cannot make any
conclusions regarding the role of heparan sulfate on embryonic
stages of differentiation. Given the large number of growth factors
and interactions involved in branching morphogenesis, we were
surprised that the alteration in sulfation did not result in failure of
the gland to undergo branching morphogenesis. Although it is
conceivable that deletion of the remaining 20% of Ndst1 gene
could affect branching, transplantation studies with epithelia
treated with AdCre also underwent branching in an apparently
normal manner. In marked contrast to branching, altering
heparan sulfate in this way had a striking and fully penetrant
effect on lobuloalveolar expansion in female mice, leading to
insufficient milk production to support their offspring (Fig. 6).
Thus, this is the first report of a heparan sulfate gene modification
that selectively blocks lobuloalveolar development while largely, if
not completely, sparing branching morphogenesis.
Lobuloalveolar development depends on sophisticated coordi-
nation between proliferative and apoptotic signals. During
lobuloalveolar expansion, local growth factors released from the
surrounding fat pad induce quiescent epithelia to undergo
proliferation, resulting in alveolar budding, lobuloalveolar devel-
opment and milk production. Lactogenic differentiation proceeds
normally in Ndst1-deficient glands and isolated epithelia (Fig. 7),
suggesting a discrete effect on budding and lobuloalveoli
formation. The focal defect on alveolar development presumably
arose from inefficient growth factor action due to failure to form
appropriate complexes of ligands, signaling receptors and heparan
sulfate [23]. Relevant factors at this stage of development include
one or more FGFs based on partial inhibition of lobuloalveoli in
animals bearing a dominant-negative FGFR2IIIb construct [61].
Although markedly reduced binding of FGF2 was observed in the
basement membrane of mutant gland epithelia (but not the fat pad
adipocytes, which had FGF2 binding similar to controls, Fig. 2),
the relevant FGF ligands active at this stage have yet to be
identified [15,62,63]. Mutants altered in HRGa expression and
ErbB4 receptors also show reduced lobuloalveolar development
[12]. Since both FGF signaling and ErbB4 mediated signaling are
regulated by heparan sulfate, further studies are needed to identify
the specific growth factors actually undermined by Ndst1-
deficiency in vivo. Conceivably, the alteration could also affect
the differentiation of stem cell precursors that contribute to a
specific niche in lobuloalveolar expansion [64,65].
During weaning, the mammary gland undergoes involution, in
which the secretory epithelium is destroyed and adipocyte
proliferation fills the fat pad. The first stage is characterized by
apoptosis of the epithelium, and multiple factors participate in
activation of the death pathway, including leukemia inhibitory
factor (LIF), insulin-like growth factors (IGF-I and IGF-II) and
their binding proteins (IGFBP-5), wnt and TGF-b [66]. Many of
these proapoptotic factors bind to heparan sulfate. Thus, altering
the structure of heparan sulfate by inactivation of Ndst1 could
inhibit multiple steps in the cascade, which may explain the highly
penetrant defect in Ndst1-deficient mice.
It seems likely that these studies have implications for other organ
systems that undergo branching morphogenesis, e.g. the salivary
Figure 4. Ndst1
f/fMMTVCre
+ mammary glands do not form lobuloalveoli. Whole mounts of inguinal mammary glands were used to examine
branching morphogenesis of Ndst1
f/fMMTVCre
– (A) and Ndst1
f/fMMTVCre
+ (C) D1L glands. Ndst1-deficient glands are grossly underdeveloped. (B)
Transplantation of Ndst1
f/fMMTVCre
2 epithelia into a cleared wildtype fat pad led to normal development at day 1 of lactation. (D) Transplantation of
Ndst1
f/fMMTVCre
+ epithelia showed a defect in lobuloalveoli development. (A,C): Bar =100 mm; (B, D): Bar =150 mm. n, lymph node.
doi:10.1371/journal.pone.0010691.g004
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lacrimal gland [71]. Certain growth factor-heparan sulfate interac-
tions have been proposed to act as ‘‘switches’’ during the stages of
kidney organogenesis [69]. Many of these systems appear to depend
on heparan sulfate and the array of growth factors implicated in
branching overlaps considerably with those involved in mammary
gland development. Therefore, one might predict that altering
sulfation by silencing specific sulfotransferases in these organs could
tease out different growth factor-heparan sulfate interactions
required during different stages of development in these organs.
Materials and Methods
Ethics Statement
All animals were handled in accordance with protocols for the
humane treatment of animals. This study was approved by the
IACUC and Animal Subjects Committee at the University of
California, San Diego (Protocol S99127).
Transgenic mice
Mice bearing a loxP-flanked allele of Ndst1 were described
previously [41]. The MMTV Cre line ‘‘A’’ mice in the 129
background was obtained from Dr. T. Wynshaw-Boris (University
of California, San Diego) [53,54]. Only male mice carrying the
MMTV Cre allele were used for breeding to avoid deletion of the
of the conditional allele by Cre expression in oocytes. All
experiments were done with mice on a mixed background with
littermate controls. Qualitative and quantitative aspects of
phenotype did not change with further backcrossing of Ndst1
f/f
into the C57Bl/6 background.
Cell culture
Primary mammary epithelia were isolated and cultured
following an established protocol [72]. Briefly, number 4 and 5
glands were excised and chopped with a razor blade, digested with
0.2% trypsin and 0.2% collagenase A and cells and organoids were
enriched by differential centrifugation. Multiwell tissue culture





+ (D–F, respectively) mice were stained with hematoxylin/eosin. No difference in glandular morphology was
noted at D8P, but differences in ductal density occurred at D15P, which is quantified in (G). The difference in density between mutant and wildtype
increased dramatically by D1L. Bars =125 mm.
doi:10.1371/journal.pone.0010691.g005
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2 of Ham’s F12 medium
containing 20% heat-inactivated fetal bovine serum (FBS) and
1 mg/ml fetuin. Cells were cultured in Ham’s F12 medium
containing 10% heat-inactivated FBS, 5 mg/ml insulin, 1 mg/ml
hydrocortisone, 5 ng/ml epidermal growth factor, 50 mg/ml
gentamycin, 100 U/ml penicillin, and 100 mg/ml streptomycin.
The medium was changed every two days.
Lactational differentiation was induced by established methods
[73]. Briefly, first passage mammary epithelia were plated on
serum/fetuin coated plates with Matrigel and cultured for 4 days
in DMEM/F12 media containing 5 mg/ml insulin, 1 mg/ml
hydrocortisone, 3 mg/ml prolactin, 50 mg/ml gentamycin,
100 U/ml penicillin, and 100 mg/ml streptomycin.
An adenovirus containing Cre recombinase (AdCre) was used to
inactivate Ndst1 in vitro, as described [74]. AdCre and adenovirus
containing green fluorescent protein (AdGFP) were obtained from
the Vector Core Development Lab at the University of California,
San Diego. Cells were treated twice over four days with 10
8 pfu/
ml media for 90 minutes, washed with PBS and cultured in normal
growth medium. Flow cytometry using biotinylated FGF and
streptavidin phycoerythrin-Cy5 showed .10-fold shift in fluores-
cence of ,99% of the cells [75].
Mammary gland histology
Histological analyses were performed by the Cancer Center
Histology Core at the University of California, San Diego. Whole
mounts were stained with hematoxylin. Binding of FGF2 to
heparan sulfate was measured in frozen sections of the inguinal
mammary gland using biotinylated FGF2 and HRP-streptavidin
[60]. Hematoxylin and eosin staining of sections was performed by
standard procedures.
Southern blotting and RT-PCR analysis
DNA was isolated from primary mammary epithelial from mice
of various ages using the Qiagen DNeasy tissue kit (Qiagen,
Valencia, CA). DNA (20 mg) was digested with Hind III and Bgl II
overnight and analyzed by agarose gel (0.8%) electrophoresis.
After transfer to a nylon membrane, the blot was probed with a
genomic probe located outside of the deleted exon [41].
RNA was isolated from purified mammary epithelial cells
(TRIzol reagent), reverse transcribed (Superscript III; Invitrogen,
Carlsbad, CA) and amplified using gene specific primers to each
Ndst isoform (Ndst1, Forward: GGACATCTGGTCTAAG, Re-
verse: GATGCCTTTGTGATAG; Ndst2, Forward: GATGACA-
AGAGGCAC, Reverse: CAGTGCTGGCATTGG; Ndst3, For-
ward: CCACTGCCTTGTGTC, Reverse: GGAGTACGCTCG-
GTC; Ndst4, Forward: CTAACTACTTCCACTC, Reverse:
ATGTGCACTGCATACC).
Q-PCR analysis of b-casein, whey acidic protein and keratin18
was done by the Genomics Core Facility at the University of
California San Diego. The following primers were used: b-casein,
Forward: AGGTGAATCTCATGGGACAGCT and Reverse:
TGACTGGATGCTGGAGTGAACT; whey acidic protein, For-
ward: TGCCATGTGCTGTCCCG and Reverse: CCAGCTTT-
CGGAACACCAAT; keratin 18, Forward: CAGTATGAAGCG-
CTGGCTCA and Reverse: GTGGTACTCTCCTCAATCT-
GCTGA.
Western blotting
Whole gland protein was prepared by removing the lymph node
from the number 4 mammary gland and homogenization [76].
Protein content was determined with the Bradford assay using
BSA as a standard (BioRad, Hercules, CA). Ten micrograms of
protein from whole glands or cultured cells was electrophoresed on
BioRad precast Ready gels and transferred to nitrocellulose with a
semi-dry blotting apparatus. The following antibodies were used:
Figure 6. Characterization of the lactational defect in Ndst1-









mammary glands was analyzed by quantitative RT-PCR for the expression
of whey acidic protein (WAP), b-casein, and keratin 18, genes specifically
expressed by mammary epithelial cells. Data was normalized to the
expression of GAPDH transcripts present in the sample. (B)W e s t e r n
blotting with antibodies to keratin 7 in d1L glands further confirmed that
the Ndst1
f/fMMTVCre
+ mammary glands have a reduced population of
epithelia. (C) Western blotting with antibodies to mouse milk from d1L




for milk protein except for a minor band at 67 kDa.
doi:10.1371/journal.pone.0010691.g006
Figure 7. Normal differentiation in Ndst deficient epithelia.
Mammary epithelia from Ndst1
f/f animals were treated with AdGFP or
AdCre and cultured on Matrigel in the presence of lactogenic
hormones. The lactational response was measured by Western blotting
with antibodies to milk proteins (A) and phosphorylated Stat5 (B). No
differences were observed between AdGFP and AdCre infected cells.
Milk protein induction or Stat5 phosphorylation was not detected
without the addition of lactogenic hormones.
doi:10.1371/journal.pone.0010691.g007
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Tilburg, The Netherlands); pStat5 (Tyr694), and keratan-7. HRP-
conjugated anti-mouse and anti-goat IgG were obtained from
BioRad (Hercules, CA). HRP was detected using the SuperSignal
West Pico chemiluminescent substrate (Pierce, Rockford, Il).
Heparan sulfate analysis
Subconfluent primary mammary epithelial cells were cultured
for 48 hours in DMEM containing 2 mM glucose, 10% dialyzed
FBS, 5 mg/ml insulin, 1 mg/ml hydrocortisone, 5 ng/ml epider-
mal growth factor and 50 mCi/ml [6-
3H]glucosamine (New
England Nuclear, Waltham, MA). Cell associated and secreted
glycosaminoglycans were isolated, cleaved with nitrous acid
pH 1.5 [58], and fractionated by gel filtration chromatography
as described [59].
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